CRISPR
The CRISPR revolution isn’t a future possibility—it’s reshaping human health, food security, and environmental sustainability simultaneously. Yet most corporate audiences hear about gene editing from venture capitalists or tech futurists, not from the researchers who understand both the extraordinary potential and the critical limitations across these interconnected domains.
Your next conference needs speakers who can explain why CRISPR therapeutics represent a $200 billion medical market while CRISPR-edited crops could feed an additional 200 million people and CRISPR-engineered microorganisms could capture gigatons of atmospheric carbon. Thermal Speakers represents the gene editing pioneers who can discuss everything from breakthrough treatments curing sickle cell disease to drought-resistant wheat varieties to engineered algae producing sustainable biofuels.
These are the voices that can help your audience understand why some CRISPR applications will succeed spectacularly while others will fail expensively—whether you’re evaluating therapeutic development, agricultural investments, or climate technology portfolios. The regulatory pathways differ dramatically between editing human cells, food crops, and environmental microorganisms, yet the underlying science connects all three applications.
When your stakeholders need to understand how gene editing will simultaneously transform healthcare delivery, agricultural productivity, and climate mitigation strategies, only Thermal Speakers provides access to the scientists who are actually designing the trials, engineering the crops, developing the carbon capture systems, and building the companies that will define our genetic future.